Tirzepatide weight-loss injection
Describe Tirzepatide and describe the workings of our program.
Tirzepatide injection is an agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor.
Weight loss from baseline to 40 treatment weeks revealed that tripeptide (5 mg, 10 mg, and 15 mg) provided at least 30%, 60%, and up to 95% more weight loss than semaglutide (1 mg).
Reviews
There are no reviews yet.